Amoxapine

From Wikipedia, the free encyclopedia

Jump to: navigation, search
Amoxapine
Systematic (IUPAC) name
2-Chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine
Identifiers
CAS number 14028-44-5
ATC code N06AA17
PubChem 2170
DrugBank APRD00142
ChemSpider 2085
Chemical data
Formula C17H16ClN3O 
Mol. mass 313.781
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Metabolism Hepatic (cytochrome P450 system)
Half life 8-10 hours (30 hours for major metabolites)
Excretion Renal
Therapeutic considerations
Pregnancy cat.

C(US)

Legal status

-only(US)

Routes Oral
 Yes check.svgY(what is this?)  (verify)

Amoxapine (sold as Asendin, Asendis, Defanyl, Demolox, Moxadil) is a tetracyclic antidepressant (TeCA) of the piperazine and dibenzoxazepine chemical classes.

Contents

[edit] Uses

It is used in the treatment of depression, anxiety disorders, panic disorder, and bipolar disorder.

It also has action similar to an atypical antipsychotic.[1]

[edit] Pharmacology

Amoxapine is a strong reuptake inhibitor of norepinephrine and weak reuptake inhibitor of serotonin.

[edit] Side effects

One of its major metabolites, 7-hydroxyamoxapine, has a dopamine receptor blocking effect, making this drug a common cause of neuroleptic malignant syndrome. Amoxapine is also associated with acute extra pyramidal symptoms and tardive dyskinesia.

Adverse effects of amoxapine include amenorrhoea and milk discharge.[citation needed]


[edit] See also

[edit] References

  1. ^ Apiquian R, Fresan A, Ulloa RE, et al. (December 2005). "Amoxapine as an atypical antipsychotic: a comparative study vs risperidone". Neuropsychopharmacology 30 (12): 2236–44. doi:10.1038/sj.npp.1300796. PMID 15956984. http://dx.doi.org/10.1038/sj.npp.1300796. 

[edit] Further reading

  • Mosby Year-Book, Inc. (1995). Physician's GenRx: The Complete Drug Reference (5th Ed.). Riverside, CT: Denniston Publishing Co.
  • Palfai, T. & Jankiewicz, H. (1997). Drugs and Human Behavior (2nd Ed.). Madison, WI: Brown & Benchmark.
  • Hedges, D. & Burchfield, C. (2006). Mind, Brain, and Drug: An Introduction to Psychopharmacology. Boston, MA: Pearson.